Rimonabant is a selective cannabinoid type 1 (CB1) receptor blocker that is part of the newly discovered endocannabinoid (EC) system. The EC plays an important role in the central and peripheral regulation of energy balance and body composition, offering a new target to induce weight loss and improve carbohydrate and lipid metabolism./.../
No comments:
Post a Comment